Mr. Brook is a Research Associate for Emerald Advisers. He joined the research team in February 2026. Prior to joining Emerald, Mr. Brook co-founded NeoCell Technologies, a biotechnology company focused on enabling PET imaging for cell and gene therapies. Before that, he held various roles in strategy consulting and investment banking across healthcare verticals. Mr. Brook graduated in 2020 from the University of Pennsylvania with a B.A. in Economics.